AVE Science & Technology Co

AVE Science & Technology Co Net Change in Cash

The Net Change in Cash of AVE Science & Technology Co (688067.SS) as of Nov 16, 2026 is -6.03 M CNY. In the previous year, Net Change in Cash was -29.08 M CNY — a change of -79.28% (higher).

Net Change in Cash

-6.03 MCNY

YoY

-79.28%

Last updated:

Net Change in Cash of AVE Science & Technology Co is 2025 -6.03 M CNY. Net Change in Cash of AVE Science & Technology Co was 2024 -29.08 M CNY. It decreases by -79.28% higher compared to the previous year.

The AVE Science & Technology Co Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2018
14.44 M CNY
Jan 1, 2019
-7.28 M CNY
Jan 1, 2020
-6.45 M CNY
Jan 1, 2021
209.05 M CNY
Jan 1, 2022
-78.41 M CNY
Jan 1, 2023
-67.08 M CNY
Jan 1, 2024
-29.08 M CNY
Jan 1, 2025
-6.03 M CNY
The AVE Science & Technology Co Net Change in Cash history
YEARNet Change in CashYoY
-6.03 MCNY-79.28%
-29.08 MCNY-56.65%
-67.08 MCNY-14.45%
-78.41 MCNY-137.51%
209.05 MCNY-3,343.32%
-6.45 MCNY-11.47%
-7.28 MCNY-150.44%
14.44 MCNY-166.20%
-21.80 MCNY-356.60%
8.50 MCNY-5,561.95%
-155,579.00CNY-97.39%
-5.97 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co., Ltd. generates revenue through the research, development, production, sale, and service of clinical testing and analysis instruments. Its main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables. These products are primarily sold to inspection departments within medical and health institutions in both domestic and overseas markets. The company serves healthcare facilities that require diagnostic equipment for laboratory testing and patient care. The firm's product portfolio targets healthcare institutions seeking advanced diagnostic tools for efficient clinical analysis. By focusing on specialized instruments like urine and stool analyzers, AVE Science & Technology addresses specific needs in medical testing departments. The company's domestic and international distribution channels ensure broad market access for its diagnostic solutions. AVE Science & Technology's revenue streams are derived from the sale of its comprehensive range of clinical testing instruments and related consumables. The company's domestic market presence and overseas sales contribute to its overall business performance. Its products support routine diagnostic procedures across various healthcare settings, driving consistent demand for its equipment and reagents. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

Net Change in Cash of AVE Science & Technology Co is -6.03 M CNY in 2025.

Net Change in Cash of AVE Science & Technology Co changed from -29.08 M CNY to -6.03 M CNY, representing a -79.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's AVE Science & Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — AVE Science & Technology Co

All Key Metrics — AVE Science & Technology Co